Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IDEAYA Biosciences (IDYA) EBIT (2020 - 2025)

Historic EBIT for IDEAYA Biosciences (IDYA) over the last 6 years, with Q4 2025 value amounting to -$94.6 million.

  • IDEAYA Biosciences' EBIT rose 3438.93% to -$94.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$197.1 million, marking a year-over-year increase of 3970.52%. This contributed to the annual value of -$159.3 million for FY2025, which is 5127.67% up from last year.
  • IDEAYA Biosciences' EBIT amounted to -$94.6 million in Q4 2025, which was up 3438.93% from $108.5 million recorded in Q3 2025.
  • Over the past 5 years, IDEAYA Biosciences' EBIT peaked at $108.5 million during Q3 2025, and registered a low of -$144.1 million during Q4 2024.
  • Over the past 5 years, IDEAYA Biosciences' median EBIT value was -$26.4 million (recorded in 2022), while the average stood at -$31.1 million.
  • In the last 5 years, IDEAYA Biosciences' EBIT tumbled by 517969.7% in 2023 and then surged by 26212.76% in 2025.
  • IDEAYA Biosciences' EBIT (Quarter) stood at -$18.4 million in 2021, then crashed by 43.95% to -$26.4 million in 2022, then plummeted by 58.52% to -$41.9 million in 2023, then plummeted by 243.87% to -$144.1 million in 2024, then skyrocketed by 34.39% to -$94.6 million in 2025.
  • Its EBIT was -$94.6 million in Q4 2025, compared to $108.5 million in Q3 2025 and -$144.1 million in Q4 2024.